Press Release: Squire Patton Boggs appoints new life sciences leader

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Cookies Settings

Press Release: Squire Patton Boggs appoints new life sciences leader

Sponsored by

Squire Patton Boggs

Squire Patton Boggs selects Janice Rice to lead the life and health sciences patent team

(PALO ALTO/SAN FRANCISCO – December 16, 2019) – Squire Patton Boggs is pleased to announce the appointment of partner Janice Rice to Deputy Practice Group Leader of the Intellectual Property & Technology Practice Group, leading the life and health sciences patent team. Ms. Rice will succeed Cameron Kerrigan, who founded the practice. Mr. Kerrigan will continue to be a partner in the practice group in the Palo Alto and San Francisco offices.

“Cameron has been dedicated to the founding and growth of the group for almost 20 years. Without him, we would not have a globally recognized life and health sciences patent practice. We thank him for his hard work and leadership,” said David S. Elkins, global chair of the Intellectual Property & Technology Practice Group. “And we are very confident that Janice will successfully continue Cameron’s hard work. She has excelled in her practice, business development and acumen, and has the skills necessary to excel as Deputy Practice Group Leader.”

Ms. Rice has been a patent lawyer for more than 16 years in the California community. For more than 12 years of that time, she served as in-house patent counsel at small to mid-sized pharmaceutical companies. Before law school, Ms. Rice worked for nine years as a synthetic organic chemist. Using her knowledge of chemistry and law, Ms. Rice’s practice includes developing US and international patent strategies, patent drafting and prosecution, evaluation and protection of trade secrets, patentability and freedom to operate analyses, patent due diligence and advising on intellectual property licensing issues.

“I am extremely proud of the strength of the Squire Patton Boggs life sciences group, and in particular, our unwavering focus on providing strategic business advice and on quality service to our clients. It is an honor to be part of such a strong team,” said Ms. Rice.

Moving forward in the role, Ms. Rice plans to continue to strengthen the business development practices of the group, bring her corporate experience to continue to build a strong team atmosphere for colleagues around the globe, and to continue the firm’s commitment to foster the growth of each individual and encouragement of women in particular, to take risks and follow their intuition.

 

ENDS

more from across site and SHARED ros bottom lb

More from across our site

The firm has taken the bold step of ditching the billable hour as its default pricing mechanism – watch now as rivals follow suit
The IP services provider is targeting further expansion as cost and efficiency pressures push law firms and in-house teams to rethink how they manage global portfolios
Two experienced UPC practitioners join the UK IP boutique’s growing German operation, with further recruitment planned as the firm expands in Europe
The Australian IP firm is taking on bigger rivals in Southeast Asia, betting that agility and transparent pricing can help it stand out
The firm has brought in former Weil IP leaders Doug Lumish and Jeff Homrig as it looks to deepen its patent, trade secrets and ITC bench
Bird & Bird helps GSK score a major injunction as the battle to become the UPC’s busiest division tightens, and overall filings reach a new monthly high
CEO Annette Bach explains how the Danish IP consultancy plans to build on its 65% profit growth while keeping external investment off the table for now
Belgian attorneys have revived fax systems to protect clients’ filing rights, while uncertainty over exposed patent data has left firms struggling to answer questions about the breach
In his first interview since leaving Weil Gotshal & Manges, Chris Henry explains why he returned to Latham and how he plans to bolster its tech disputes offering
As GTA VI underlines the extraordinary value of gaming franchises, lawyers at Clifford Chance say investors need to know the IP behind their next deal can deliver the growth they are paying for
Gift this article